19-3005856-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_003260.5(TLE2):c.1613G>T(p.Arg538Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003260.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248684Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135050
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461654Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727118
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1613G>T (p.R538L) alteration is located in exon 16 (coding exon 16) of the TLE2 gene. This alteration results from a G to T substitution at nucleotide position 1613, causing the arginine (R) at amino acid position 538 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at